2013-05-14T20:23:29-05:00 2012-09-30 202153727 SB & Company LLC 200 International Circle Suite 5500 Hunt Valley MD 21030 990 2011-10-01 237448063 Lupus Foundation of America DCMDVA Chapter Inc LUPU 2023491173 2000 L Street NW No 415 Washington DC 20036 Jessica Gilbart 2023491173 2013-05-14 1 Graylin Smith P00644233 4105840060 2013-05-14 2011 2016-03-07 17:11:31Z Penelope C Fletcher 2000 L Street NW No 415 Washington DC 20036 818367 0 X wwwlupusdmv.org X 1974 DC To serve the needs of those affected directly and indirectly by Lupus through education, support activities and research. 13 13 21 457 0 0 477544 413562 0 0 0 3 221220 294630 698764 708195 2291 758 0 0 463425 452332 0 0 14984 274852 407616 740568 860706 -41804 -152511 102629 86464 138758 275104 -36129 -188640 To serve the needs of those affected directly and indirectly by Lupus through education, support activities and research. 0 0 342219 209 Public awareness and information dissemenation through symposium workshops and newsletter. 312120 Patient services providing support group meetings and physician referral services. 654339 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 12 0 1 21 1 0 0 0 0 0 0 0 0 X 13 13 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 DC MD VA X The Foundation Officers 2023491173 2000 L Street NW Suite 415 Washington DC 20036 Elizabeth A Murphy 5.00 X X 0 0 0 Steven Beaton 3.00 X X 0 0 0 Ted Davies 4.00 X X 0 0 0 Matthew J Marino 2.00 X X 0 0 0 Marguerete Luter 4.00 X 0 0 0 Jim Katz 1.00 X 0 0 0 Cheryl Walton 1.00 X 0 0 0 Romy Matta Barrera 1.00 X 0 0 0 Stephanie Laumann 1.00 X 0 0 0 Lynn Mckinley-Grant 1.00 X 0 0 0 Lynne Kaye 1.00 X 0 0 0 Ted Mannen 1.00 X 0 0 0 Coleen Bertsch 3.00 X 0 0 0 Brandon Clairmont 1.00 X 0 0 0 Denise Harrison 1.00 X 0 0 0 Tutu Lawal 1.00 X 0 0 0 Stephanie Lyons 1.00 X 0 0 0 Arthur Weinstein 1.00 X 0 0 0 Richard Watson 3.00 X 0 0 0 Pamela Greenburg 3.00 X 0 0 0 Trevor Williams 2.00 X 0 0 0 Penelope Fletcher 40.00 X 121608 0 8736 121608 0 8736 1 0 0 0 0 61650 351912 19255 413562 3 3 404593 61650 110172 294421 294421 Other Revenue 900099 209 209 209 708195 209 0 294424 758 758 130343 95090 32510 2743 274665 225979 43458 5228 15522 8923 5051 1548 31802 31802 18689 18689 7277 7242 35 11660 11042 198 420 82686 67103 12191 3392 106836 72656 33808 372 27721 26045 1619 57 8607 8607 7891 7891 19555 14371 3995 1189 Lupus research 104697 104697 11997 11826 171 860706 654339 191383 14984 12499 6295 44564 52630 19847 9711 31990 14162 25719 17828 102629 86464 78396 100624 22770 25344 37592 149136 138758 275104 X -36129 -188640 -36129 -188640 102629 86464 -152511 0 X X 1 1 1 X 0 X 172221 192055 702996 477544 477810 2022626 172221 192055 702996 477544 477810 2022626 2022626 49 86 82 3 220 4021 251 4806 209 9287 2032133 1197143 0.99530 0.99440 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 31990 14162 17828 17828 Loan payable - Lupus Foundation of America 124721 Capital lease obligation 5066 Bank overdraft 19349 149136 708195 860706 -152511 -152511 883364 64997 110172 175169 708195 0 708195 1035875 64997 110172 175169 860706 0 860706 Part XII, Line 2d - Other Adjustments: Special Event Expenses 110,172. Part XIII, Line 2d - Other Adjustments: Special Event Expenses 110,172. Washington, DC Walk 278779 19483 259296 9077 88 38882 Baltimore Walk 96509 15460 81049 3808 375 13136 3 90955 26707 64248 2100 12029 14480 16197 466243 61650 404593 2100 24914 14943 68215 110172 294421 Form 990, Part VI, Section B, line 11 A copy of the Form 990 is sent out via e-mail by CEO and circulated to the Audit Committee. It is distributed to the Board electronically before their annual review of the audit. It is then distributed to the Board in printed format at that meeting and mailed to each board member who is not in attendance at that meeting along with a printed copy of the audit. Form 990, Part VI, Section B, line 12c New board members and staff are required to receive a copy of the conflict of interest policy and must sign a conflict of interest statement confirming that they have received the conflict of interest policy, are adhering to that policy and notifying the organization of any conflicts of interest. All board members and staff are required to sign the conflict of interest statements annually. Form 990, Part VI, Section B, line 15a The compensation of the organization's CEO is determined by the board which is run by the Board Chair. The board has a review process which they use to determine the CEO's compensation. Goals are set by the board and the CEO at the beginning of the fiscal year. If there is a bonus arrangement then it is set using those goals. Periodic review of the goals is done by the CEO and Board Chair together during the year. After the conclusion of the fiscal year, a performance review is done by the board using the CEO's goals for the year. A self-evaluation by the CEO is prepared for use in that process. Comparative data is used to determine the amount of compensation increase. The Board Chair meets with the CEO to review their performance and discuss compensation. The CEO's bonus is a calculation based upon a formula which is documented in a bonus agreement between the board and the CEO. The Board Treasurer computes the figures and the Board Chair authorizes the payment of the bonus. No other officers are compensated. Form 990, Part VI, Section C, line 19 The Organization makes its governing documents, conflict of interest policy, and financial statements available to the public upon request. Form 990, Part XII. Line 2c The process has not changed from prior year. Lupus Foundation of America Inc 2000 L Street NW Suite 710 Washington DC 20036 431131436 Lupus research & supporting services DC 501(c)(3) Line 7 N/A 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0